Lou Gehrig's disease

cash money

Pharma

Amylyx's first approval may carry a steep price, ICER argues

Amylyx’s drug is up for a decision at the U.S. FDA by Sept. 29, 2022.

Fraiser Kansteiner Jun 15, 2022 9:46am

Radicava

Oral version of Mitsubishi's ALS drug Radicava gets FDA blessing

May 13, 2022 9:31am

Radicava

Mitsubishi's Radicava ready to roll with ALS nod

May 8, 2017 10:45am